Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Decides to Establish Genomics Center After Failing to Find Partner


BASEL, Switzerland--The decision by Novartis to invest $250 million to build a genomics research center in California (see BioInform, April 13) came after several failed attempts to find a partner.

Paul Herrling, head of basic research, said that when Novartis looked at companies active in the genomics field, "We saw that they all were specialized in one or the other technology--bioinformatics, mouse transgenes, worm, proteomics--but none were integrated, none had available all of these techniques. We firmly believe that in order to solve gene function it is important to have all of these techniques available in one place."

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.